These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315 [No Abstract] [Full Text] [Related]
3. Glucagon releasing activity of a cyclic peptide related to somatostatin. Lyle TA; Freidinger RM; Nutt RF; Homnick CF; Saperstein R; Veber DF Int J Pept Protein Res; 1987 Feb; 29(2):244-9. PubMed ID: 2883151 [TBL] [Abstract][Full Text] [Related]
4. A bicyclo-somatostatin analog, highly specific for the inhibition of growth hormone release. Sarantakis D; Teichman J; Clark DE; Lien EL Biochem Biophys Res Commun; 1977 Mar; 75(1):143-8. PubMed ID: 849303 [No Abstract] [Full Text] [Related]
5. Comparison of cylic and linear forms of somatostatin in the inhibiton of growth hormone, insulin and glucagon Secretion. Leblanc H; Yen SS J Clin Endocrinol Metab; 1975 May; 40(5):906-8. PubMed ID: 1127098 [TBL] [Abstract][Full Text] [Related]
6. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog. Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285 [No Abstract] [Full Text] [Related]
7. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity. Garsky VM; Clark DE; Grant NH Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of glycosylated analogs of somatostatin. Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658 [No Abstract] [Full Text] [Related]
9. Superactive octapeptide somatostatin analogs containing tryptophan at position 1. Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520 [TBL] [Abstract][Full Text] [Related]
10. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients. Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329 [TBL] [Abstract][Full Text] [Related]
11. Common structural features for cytoprotection activities of somatostatin, antamanide and related peptides. Kessler H; Gehrke M; Haupt A; Klein M; Müller A; Wagner K Klin Wochenschr; 1986; 64 Suppl 7():74-8. PubMed ID: 2882054 [No Abstract] [Full Text] [Related]
12. Structure activity studies on somatostatin. Sarantakis D; McKinley WA; Jaunakais I; Clark D; Grant NH Clin Endocrinol (Oxf); 1976; 5 Suppl():275S-278S. PubMed ID: 1052780 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid. Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830 [TBL] [Abstract][Full Text] [Related]
14. [des-Ala1, Gly2]-His4,5D-Trp8-somatostatin: a glucagon-specific and long-acting somatostatin analog. Sarantakis D; Teichman J; Fenichel R; Lien E FEBS Lett; 1978 Aug; 92(2):153-5. PubMed ID: 700091 [No Abstract] [Full Text] [Related]
16. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells. Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980 [TBL] [Abstract][Full Text] [Related]